Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction

Anna M Michalowska, Wenhao Zhang, Aakash Shanbhag, Robert JH Miller, Mark Lemley, Giselle Ramirez, Mikolaj Buchwald, Aditya Killekar, Paul B Kavanagh, Attila Feher, View ORCID ProfileEdward J Miller, View ORCID ProfileAndrew J Einstein, Terrence D Ruddy, Joanna X Liang, Valerie Builoff, View ORCID ProfileDavid Ouyang, Daniel S Berman, Damini Dey, Piotr J Slomka
doi: https://doi.org/10.1101/2024.04.23.24305735
Anna M Michalowska
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenhao Zhang
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aakash Shanbhag
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
2Signal and Image Processing Institute, Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert JH Miller
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
3Department of Cardiac Sciences, University of Calgary, Calgary AB, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Lemley
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giselle Ramirez
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikolaj Buchwald
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditya Killekar
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul B Kavanagh
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Attila Feher
4Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward J Miller
4Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward J Miller
Andrew J Einstein
5Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, New York, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J Einstein
Terrence D Ruddy
6Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna X Liang
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Builoff
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Ouyang
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Ouyang
Daniel S Berman
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damini Dey
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piotr J Slomka
1Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Piotr.Slomka{at}cshs.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background While low-dose computed tomography scans are traditionally used for attenuation correction in hybrid myocardial perfusion imaging (MPI), they also contain additional anatomic and pathologic information not utilized in clinical assessment. We seek to uncover the full potential of these scans utilizing a holistic artificial intelligence (AI)-driven image framework for image assessment.

Methods Patients with SPECT/CT MPI from 4 REFINE SPECT registry sites were studied. A multi-structure model segmented 33 structures and quantified 15 radiomics features for each on CT attenuation correction (CTAC) scans. Coronary artery calcium and epicardial adipose tissue scores were obtained from separate deep-learning models. Normal standard quantitative MPI features were derived by clinical software. Extreme Gradient Boosting derived all-cause mortality risk scores from SPECT, CT, stress test, and clinical features utilizing a 10-fold cross-validation regimen to separate training from testing data. The performance of the models for the prediction of all-cause mortality was evaluated using area under the receiver-operating characteristic curves (AUCs).

Results Of 10,480 patients, 5,745 (54.8%) were male, and median age was 65 (interquartile range [IQR] 57-73) years. During the median follow-up of 2.9 years (1.6-4.0), 651 (6.2%) patients died. The AUC for mortality prediction of the model (combining CTAC, MPI, and clinical data) was 0.80 (95% confidence interval [0.74-0.87]), which was higher than that of an AI CTAC model (0.78 [0.71-0.85]), and AI hybrid model (0.79 [0.72-0.86]) incorporating CTAC and MPI data (p<0.001 for all).

Conclusion In patients with normal perfusion, the comprehensive model (0.76 [0.65-0.86]) had significantly better performance than the AI CTAC (0.72 [0.61-0.83]) and AI hybrid (0.73 [0.62-0.84]) models (p<0.001, for all).CTAC significantly enhances AI risk stratification with MPI SPECT/CT beyond its primary role - attenuation correction. A comprehensive multimodality approach can significantly improve mortality prediction compared to MPI information alone in patients undergoing cardiac SPECT/CT.

1. Introduction

Myocardial perfusion scintigraphy is widely used for the evaluation of coronary artery disease (CAD), with over 15-20 million scans performed worldwide.1,2 During myocardial perfusion imaging (MPI), a low-dose non-contrast computed tomography attenuation correction (CTAC) scan is often used to correct for soft-tissue attenuation, leading to improved diagnostic accuracy.3,4 Attenuation correction by computed tomography (CT) is recommended by American Society of Nuclear Cardiology guidelines.5 Although the myocardium is the structure of principal interest during SPECT/CT MPI, its CTAC scan provides a wealth of additional information about other visible organs. Incidental findings have been reported in up to 59.5% of SPECT/CT MPI studies, of which some are clinically important and necessitate further diagnosis and treatment.6,7

However, due to limitations in the quality of CTAC images (low dose, no electrocardiographic gating), detection and characterization of abnormal findings on CTAC can be challenging.8 Consequently, the additional information present in hybrid cardiac scans is often underutilized during clinical reporting. While some methods have been developed to derive information about coronary artery calcium (CAC) and epicardial adipose tissue (EAT) from CTAC scans, 9,10 many other potentially clinically important features, like extracardiac structures, are present in these scans, yet to date their added value to MPI has not been systematically evaluated.

The aim of this study is to develop a holistic artificial intelligence (AI)-based approach for the prediction of all-cause mortality from SPECT/CT MPI utilizing all possible information contained in the hybrid images and to separately evaluate the value of CTAC images for this purpose, which have been previously underutilized.

2. Material and methods

2.1 Study population

In this retrospective study we utilized CTAC scans of patients who underwent SPECT/CT MPI from 4 sites (University of Calgary, Yale University, Columbia University, University of Ottawa Heart Institute) participating in the Registry of Fast Myocardial Perfusion Imaging with Next generation SPECT (REFINE SPECT).11 The study protocol was approved by the IRB at all participating sites and complied with the Declaration of Helsinki. Baseline demographic and clinical characteristics were obtained from the REFINE SPECT registry.11 CTAC image acquisition at each participating site is shown in Table S1. The outcome was all-cause mortality (referred to subsequently simply as “mortality”), which was determined using the national death index for sites in the United States and administrative databases in Canada.

2.2 Myocardial Perfusion Image Analysis

Total perfusion deficit (TPD), end-diastolic stress shape index (ratio between the maximum left ventricular (LV) diameter in short axis and the length of the LV in end-diastole at stress), stress ejection fraction, and end-diastolic volume were quantified automatically from non-attenuation-corrected MPI scans at the core laboratory (Cedars-Sinai Medical Center, Los Angeles) with the use of dedicated software (Quantitative Perfusion SPECT [QPS] software, Cedars-Sinai Medical Center, Los Angeles)12. Normal myocardial perfusion was defined as stress TPD <5%13, whereas moderate-to-severe ischemia was defined as TPD ≥10% of the myocardium.14

2.3 Multi-structure deep learning feature extraction from CTAC

The study design is shown in Figure 1. TotalSegmentator, a multi-structure segmentation deep learning (DL) model, was used to segment structures visible on CTAC.15 Out of all segmented structures, we selected thirty-three structures with a frequency of >80% on all scans (Figure S1). The automatic extraction of imaging features for all selected structures was performed with PyRadiomics package (version 3.0.1).16 In per-organ analysis, we included eleven first-order and four 3D features (Table S2).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Central illustration.

Artificial intelligence (AI) model integrating fully automated multi-structure computed tomography attenuation correction (CTAC) segmentation, quantitative image analysis (radiomics), deep learning (DL)-based coronary artery calcium (CAC), and epicardial adipose tissue (EAT) in all patients undergoing myocardial perfusion imaging (MPI) single-photon emission computed tomography/computed tomography (SPECT/CT). Receiver-operating characteristics curve for all-cause mortality and area under the receiver-operating characteristic curve values of Coronary calcium (DL-CAC score), Perfusion (stress TPD), the AI CTAC model (including DL-CAC, DL-EAT, and radiomics); the AI hybrid model – combing the CTAC model with stress MPI quantitative image parameters and stress variables and the All model incorporating AI hybrid image features, and clinical data.

2.4 Automated Coronary Artery Calcium Scoring

Our formerly validated deep learning model was used for CAC segmentation and scoring.17,18 To segment heart mask and CAC on CTAC images, two convolutional long short-term memory (convLSTM) networks were tested externally on data (10,480 CTAC scans) from 4 different sites. To automatically obtain CAC scores from the deep learning segmentation, established methods were used.19

2.5 Automated Epicardial Adipose Tissue Scoring

A previously developed deep learning model was used to estimate EAT volume and density (-190 and -30 Hounsfield units [HU]) from CTAC scans.10 For EAT model training and validation purposes, we used 500 CTAC scans from one site (Yale University). Patients who were used for EAT model training and validation were not included in this analysis.

2.6 Classification Models

Extreme Gradient Boosting (XGBoost) models (version 1.7.3), a currently leading machine learning method, were used for mortality classification. These models generate all-cause mortality risk scores by applying 10-fold cross-validation regimen across the entire dataset. Within each fold, 90% of the data was first set aside for model training and validation. This 90% was further divided, with 80% used for training and 20% for validation. The remaining 10% of the data in each fold was used for testing and kept separate from training and validation to ensure each patient was tested exactly once across all folds. 10 separate models were built, and each was tested independently. Testing results were concatenated from all models for the overall performance evaluation. Hyper-parameter tuning to optimize the model parameters was conducted during training and validation, separately in each fold using the grid-search method.

Three key benefits of employing 10-fold cross-validation are primarily 3-fold: 1) it reduces the variability of prediction errors, leading to a more accurate evaluation; 2) it maximizes the data utilization while minimizing the chance of overfitting and cross-contamination of information among data splits; 3) it guards against validating the hypothesis influenced by arbitrary data split (Type III error).20,21

2.7 Models

Four models were used for the mortality endpoint: 1 – model incorporating DL-EAT (EAT), 2 – model combining quantitative CTAC image analysis of all segmented structures [radiomics], DL-EAT and DL-CAC (AI CTAC), 3 – model incorporating all variables included in the CTAC model as well as stress ejection fraction, stress end-diastolic volume, stress shape index end-diastolic, stress TPD, and other SPECT imaging features [see Table S3] (AI hybrid), 4 – model combining CTAC, MPI and clinical data (All), whereas Coronary calcium (DL-CAC score) and Perfusion (utilizing stress TPD) were univariate comparisons.

Clinical data include patient demographics such as age, sex, body mass index [BMI]. Also included is past medical history: hypertension, diabetes, dyslipidemia, prior CAD (prior myocardial infarction, percutaneous coronary intervention [PCI], and coronary artery bypass graft [CABG]). Further, the clinical data encompass variables from stress test such as the type of test, peak stress heart rate, peak stress blood pressure, and ECG response to stress.

2.8 Model Explainability

The predictive power of variables included in model training was evaluated using XGBoost feature importance, which quantifies the increase in accuracy resulting from the addition of each feature. SHapley Additive exPlanations (SHAP), a game-theoretic feature importance method, was used to explain how structures contributed to the overall risk in model inference for individual patients.22

2.9 Thresholds for Comparisons of Machine Learning

Patients were classified into low or high-risk groups based on AI-derived all-cause mortality risk score. This classification was achieved by setting a threshold that aligns with the proportion of patients identified by the established clinical criteria for ischemia (≥10%).23,24

2.10 Statistical Analysis

Continuous variables with a normal distribution are presented as mean ± standard deviation (SD) and not normally distributed variables as medians with interquartile range (IQR) [IQ1-IQ3]. Categorical variables are expressed as count and relative frequencies (percentages). Differences between categorical variables were compared by the Pearson’s χ2 test whereas continuous variables were compared by Wilcoxon Mann-Whitney test, as appropriate. The performance of the models was evaluated using receiver-operating characteristics analysis, and area under the receiver-operating characteristic (AUC) analysis values were compared with the DeLong test.25 Kaplan-Meier survival curve, alongside univariate Cox proportional hazard models, were employed to evaluate the association with mortality. Log-rank test was used to ascertain the statistical significance. The improvement in model predictions was measured using the time-dependent net reclassification improvement score at 2 years.26 Confidence intervals were calculated by the percentile bootstrap method. A two-tailed p-value of <0.05 was considered statistically significant. All statistical analyses were performed with Pandas (version 2.1.1) and Numpy (version 1.24.3), Scipy (version 1.11.4), Lifelines (version 0.28.0) and Scikit-learn (version 1.3.0) in Python 3.11.5 (Python Software Foundation, Wilmington, DE, USA), as well as “nricens” package (version 1.6) in R version 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria).

3. Results

3.1 Patient Characteristics

Study population

In total 10,983 participants from 4 sites were enrolled in the REFINE SPECT registry, of which 500 CTAC scans from one site were used for EAT-model training and validation. Of the 10,483 remaining participants, 3 were excluded due to incomplete CTAC scans. The final study cohort consisted of 10,480 participants (Figure S2).

Table 1 represents baseline characteristics stratified by sex. Of all participants, 5,745 (54.8%) were male, and median age was 65 (57, 73) years. During the median 2.9-year (1.6-4.0) follow-up period, 651 (6.2%) patients died. Normal myocardial perfusion was present in 6,165 (58.8%) patients, of whom 274 (4.4%) died. Patients with normal perfusion were significantly younger (p<0.001), more often female, and less often diagnosed with hypertension (p<0.001), diabetes (p<0.001), and dyslipidemia (p=0.007) (Table S4).

View this table:
  • View inline
  • View popup
Table 1. Baseline characteristics for all participants stratified by sex

Myocardial Imaging Perfusion Quantitative Image Analysis Parameters

In all patients, the median total perfusion deficit (TPD) was 2.6% (0.9-6.0) and was higher in male than female patients (2.7 vs. 2.5, respectively, p<0.001) (Table 1). Significantly lower stress ejection fraction was observed in men compared with women (59% vs. 70%, respectively, p<0.001). The median TPD in patients with abnormal perfusion was 7.0 (4.9-11.7), whereas the median stress ejection fraction in this group was 59 (49-68) (Table S4).

Coronary Artery Calcium and Epicardial Adipose Tissue

CAC was 0 in 3,753 (35.8%) patients, >0-100 in 1,982 (18.9%), >100-400 in 1,462 (14.0%), and >400 in 3,283 (31.3%) subjects. The median EAT volume and density were 130 mL (90, 183) and -65 HU (-70, -61), respectively (Table 1).

In patients with normal perfusion, 2,459 (39.9%) subjects had no CAC, 1,305 (21.2%) had CAC >0 and ≤100, 862 (14.0%) had CAC >100 and ≤400, and 1,539 (25.0%) had CAC >400. The median EAT volume and density in patients with normal perfusion were 129 mL (89, 179) and -65 HU (-70, -61), respectively (Table S4).

3.2 Model Performance

Figure 2 represents the model performance and feature importance for mortality in all patients, subjects with normal perfusion, and patients without calcified lesions in coronary arteries. The lungs were the top feature in all patients, in patients with normal perfusion as well as in subjects without coronary calcifications. Table S5 shows AUCs with 95% CI for all AI models in all patients included in the study. There was a better performance of the AI CTAC model than the EAT model (AUC 0.56, 95% CI 0.49-0.63, p<0.001), and coronary calcium (AUC 0.64, 95% CI 0.57-0.71, p<0.001) alone. There was a statistically significant difference in the prediction performance of the AI hybrid model and the CTAC model (AUC 0.79 vs. 0.78, p<0.001).

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

Model performance and feature importance scores for all-cause mortality in all patients (A), in patients with normal perfusion (B), and patients with no coronary artery calcification (C). Normal myocardial perfusion was defined as total perfusion deficit (TPD) <5%. Receiver operating characteristic curve for the AI computed tomography attenuation correction (CTAC) model, including deep-learning (DL) coronary calcium, DL-epicardial adipose tissue (EAT), and radiomics, the AI hybrid model incorporating CTAC and myocardial perfusion imaging (MPI) data (stress MPI quantitative image parameters, Coronary Calcium (DL-coronary artery calcium score), Perfusion (stress TPD), and a model combining CTAC, MPI, and clinical data, (All). In all patients, the performance of the EAT model (not shown in the figure) alone was AUC 0.56, in patients with TPD <5% AUC 0.55, whereas in subjects with no coronary calcium AUC 0.59. Feature importance score plot represents 10 segmented structures with the highest scores for the CTAC model.

AUCs with 95% CI for all AI models in patients with normal myocardial perfusion are shown in Table S6 whereas in subjects with no coronary calcium in Table S7. In the group with normal perfusion, the performance of the AI CTAC model was significantly better compared to Perfusion (AUC 0.72 vs. 0.55, respectively, p<0.001). The AI hybrid model incorporating CTAC and MPI features had higher prediction performance compared to the AI CTAC-only model (AUC 0.73 vs. 0.72, respectively, p<0.001). Among the patients with no calcium, the AI CTAC model significantly outperformed Perfusion (AUC 0.71 vs. 0.59, respectively, p<0.001). The AI hybrid model was significantly better than AI CTAC-only model (AUC 0.75 vs 0.71, respectively, p<0.001).

3.3 Association with Outcomes and Multivariable Model

Kaplan-Meier Curves stratified by TPD (ischemia <10% and ≥10%), and a matched proportion of patients with high and low AI scores (AI threshold at 0.095, high risk in 9.8%) are shown in Figure 3. AI score led to an improved risk reclassification of patients who experienced mortality (23.9%, 95% CI 19.5-28.5, p<0.001), and patients who did not experience mortality (2.4%, 95% CI 1.7-3.2, p<0.001), with an overall net reclassification improvement of 26.4% (95% CI 21.8-31.0, p<0.001).

Figure 3.
  • Download figure
  • Open in new tab
Figure 3.

Kaplan-Meier curves stratified by total perfusion deficit (TPD) matched to AI scores (All model). Ischemia was defined as TPD ≥10%. Abbreviations: CI – confidence interval, NRI – Net Reclassification Improvement.

Figure S3 illustrates findings of multivariable analyses. After adjusting for age, sex (male), hypertension, dyslipidemia, diabetes mellitus, peripheral vascular disease, past myocardial infarction, and family history of CAD, patients with abnormal perfusion were at higher risk of death compared to patients with normal myocardial perfusion (adjusted hazard ratio [HR] 1.71, 95% CI 1.46-2.01, p<0.001). Moreover, CAC >400 (adjusted HR 2.11, 95% CI 1.67-2.65, p<0.001) was associated with an increased risk of death.

3.4 Structure Specific Risk Evaluation

Examples of patients classified to be at a higher risk of death (with extracardiac structures, notably the lungs and aorta, contributing the most to mortality) are shown in Figure 4.

Figure 4.
  • Download figure
  • Open in new tab
Figure 4. Examples of patients undergoing single-photon emission computed tomography/computed tomography (SPECT/CT) myocardial perfusion imaging with an extracardiac structure increasing the highest risk of all-cause mortality.

Waterfall plot demonstrates the top 10 structures with the highest influence on per-patient risk of mortality (for the computed tomography attenuation correction [CTCA] model).

Case 1: A male patient was classified to be at higher risk of death with the lungs (right lower lobe) contributing the most to the elevated risk (red arrow on the waterfall plot). A. CTAC, axial view, with a corresponding deep learning (DL) structures segmentation (B) revealed a 39x39 mm solid mass with irregular margins in the right lower lobe. CTAC with an overlayed SPECT scan showed no uptake of the radiotracer. D-E. 3D reconstruction of all segmented and ranked structures. The patient had abnormal myocardial perfusion (total perfusion deficit of 7.65) and died 48 days after the exam.

Case 2: A male patient was identified to be at elevated risk of mortality. The risk of death was increased the most by the aorta (red arrow on the waterfall plot). F. CTAC, axial view, with a corresponding DL structures segmentation (G) showed a descending aortic aneurysm (cross-sectional diameters of the descending aorta 53x51 mm at the level of the pulmonary artery bifurcation). H. CTAC with an overlayed single-photon emission tomography scan, coronal view. I-J. 3D reconstruction of all segmented and ranked structures. The patient had abnormal myocardial perfusion (total perfusion deficit of 32.1) and died 209 days after the exam.

Case 3: A male patient was assigned to be at increased risk of death. The dilated pulmonary artery was contributing the most to the elevated risk (red arrow on the waterfall plot). K. CTAC with a corresponding DL structures segmentation (L) showed a dilatated pulmonary artery (the pulmonary artery diameter on transaxial image - 32 mm). M. CTAC with an overlayed SPECT scan showed no uptake of the radiotracer. N-O. 3D reconstruction of all segmented and ranked structures. The patient had abnormal myocardial perfusion (total perfusion deficit of 9.67) and died 5.4 years after the exam.

4. Discussion

In this study, we have demonstrated the potential value of holistic anatomic, functional and clinical evaluation of CTAC scans for improving all-cause mortality prediction in patients undergoing hybrid perfusion MPI. We developed a fully automated AI model incorporating multi-structure segmentation and radiomic feature extraction in parallel to deep learning-based CAC and EAT quantification. This model improves mortality prediction from multimodality myocardial perfusion, with a combined model improving upon any feature set (SPECT, CTAC, or clinical) in isolation. Moreover, it provides physicians with guidance regarding portions of CTAC scans which require further scrutiny to identify potentially important underlying conditions indicating potentially significant incidental findings, despite coronary artery disease being the primary indication for the examination. This fully automated workflow could be leveraged by physicians to unlock the full potential of hybrid SPECT/CT imaging.

Several studies have proven the role of AI in predicting cardiovascular events from SPECT/CT using clinical, MPI 27,28, and CTAC data.29,30 Nevertheless, only a limited number of CTAC findings, like CAC29, or EAT10 were included in these previous analyses. More recently we demonstrated that deep learning cardiac chamber volumes (from CTAC) provided incremental and complementary value to CAC and SPECT variables.31 Ashrafinia et al. used radiomic features from SPECT MPI to predict CAC score derived from CT scans32, whereas Amini et al. applied a quantitative image analysis approach not only to diagnose CAD, but also for risk classification.33 The proposed AI approach integrates simultaneous assessment of multiple structures on CTAC by leveraging strengths of deep learning and quantitative image analyses. Importantly, the model incorporating SPECT, CTAC, and clinical data had the highest prediction performance suggesting that AI-derived information encrypted in CTAC is complementary to traditional methods for analysis.

By integrating functional imaging (SPECT) with anatomic characteristics (CT), hybrid imaging has not only enhanced nuclear medicine by improving diagnostic accuracy 34,35, but also provides an enormous amount of data contained in CTACs - which to date is not fully utilized. However, accurate interpretation and identification can be challenging due to image quality of these low-dose, non-electrocardiographically gated, and often free- breathing scans.8 Importantly, these auxiliary scans may be interpreted by physicians without dedicated training in interpreting chest CT.36 In some cases, unexpected intra-, and extrathoracic radiotracer uptake can lead to identification of conditions like thymoma, breast and lung cancer.37,38 Previous studies have demonstrated the ability of AI to support physicians in identifying potentially important incidental findings.39,40 Our AI model could potentially help with this clinical challenge by combining 33 cardiac and extracardiac structures automatically segmented from CTAC scans, and ranking those structures based on their importance in predicting mortality in each patient.

Limitations

This study has some limitations. It was a retrospective study with non-uniform CTAC acquisition protocols from multiple sites, however, this highlights the generalizability of the approach. Some organs were only partially visible or not visualized on all scans. For example, organs like kidneys and thyroid were excluded from the analysis because of their high missingness across the cohort. No information regarding the reported cause of death is available in this large, multicenter registry. Therefore, we are not able to evaluate the associations between organ features and cause-specific death. Finally, radiological evaluation of CTACs was performed only with radiomic features and no information regarding reported incidental findings is available in this cohort.

Conclusions

We demonstrate a significant, yet underappreciated, role of CTAC in risk stratification with MPI SPECT/CT. Fully automated AI integration of quantitative features from multiple organs derived from CTAC, perfusion and clinical data images significantly improves mortality risk stratification in patients undergoing SPECT/CT MPI as compared to MPI only.

Data Availability

To the extent allowed by data sharing agreements and IRB protocols, the data from this manuscript will be shared upon written request.

Disclosures

Dr. Robert Miller received consulting fees and research support from Pfizer. Drs. Berman and Slomka, and Paul B. Kavanagh participate in software royalties for QPS software at Cedars-Sinai Medical Center. Dr. Slomka has received consulting fees from Synektik. Drs. Berman, Einstein, and Edward Miller have served or currently serve as consultants for GE Healthcare. Dr. Einstein has received speaker fees from Ionetix; has received consulting fees from W. L. Gore & Associates; has received authorship fees from Wolter Kluwer Healthcare-UpToDate; has served on a scientific advisory board for Canon Medical Systems; and has received grants to his institution from Attralus, Bruker, Canon Medical Systems, Eidos Therapeutics, Intellia Therapeutics, Ionis Pharmaceuticals, Neovasc, Pfizer, Roche Medical Systems, and W. L. Gore & Associates. Dr. Ruddy has received research grant support from GE Healthcare and Advanced Accelerator Applications. Dr. David Ouyang reported having a patent pending for EchoNet-LVH. The remaining authors have nothing to disclose.

Data Availability Statement

To the extent allowed by data sharing agreements and IRB protocols, the data from this manuscript will be shared upon written request.

List of abbreviations

AI
artificial intelligence
AUC
area under the receiver-operating characteristic curve
BMI
body mass index
CABG
coronary artery bypass graft
CAC
coronary artery calcium
CAD
coronary artery disease
CI
confidence interval
convLSTM
convolutional long short-term memory
CT
computed tomography
CTAC
computed tomography attenuation correction
DL
deep learning
EAT
epicardial adipose tissue
HR
hazard ratio
HU
Hounsfield units
LVEF
left ventricular ejection fraction
MPI
myocardial perfusion imaging
PCI
percutaneous coronary intervention
SPECT
single-photon emission computed tomography
TPD
total perfusion deficit

Acknowledgements

This research was supported in part by grants R01HL089765 and R35HL161195 from the National Heart, Lung, and Blood Institute at the National Institutes of Health (PI: Piotr Slomka). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. MB is supported by a research award from the Kosciuszko Foundation – The American Centre of Polish Culture.

References

  1. 1.↵
    Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26(3): 639–47.
    OpenUrlFREE Full Text
  2. 2.↵
    Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012; 60(24): e44-e164.
    OpenUrl
  3. 3.↵
    Heller GV, Links J, Bateman TM, et al. American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy. J Nucl Cardiol 2004; 11(2): 229–30.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Pazhenkottil AP, Ghadri JR, Nkoulou RN, et al. Improved outcome prediction by SPECT myocardial perfusion imaging after CT attenuation correction. J Nucl Med 2011; 52(2): 196–200.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Dorbala S, Di Carli MF, Delbeke D, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1 0. J Nucl Med 2013; 54(8): 1485–507.
    OpenUrlFREE Full Text
  6. 6.↵
    Coward J, Lawson R, Kane T, et al. Multi-centre analysis of incidental findings on low-resolution CT attenuation correction images. Br J Radiol 2014; 87(1042): 20130701.
  7. 7.↵
    Goetze S, Pannu HK, Wahl RL. Clinically significant abnormal findings on the "nondiagnostic" CT portion of low-amperage-CT attenuation-corrected myocardial perfusion SPECT/CT studies. J Nucl Med 2006; 47(8): 1312–8.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Coward J, Nightingale J, Hogg P. The Clinical Dilemma of Incidental Findings on the Low-Resolution CT Images from SPECT/CT MPI Studies. J Nucl Med Technol 2016; 44(3): 167–72.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Commandeur F, Goeller M, Razipour A, et al. Fully Automated CT Quantification of Epicardial Adipose Tissue by Deep Learning: A Multicenter Study. Radiol Artif Intell 2019; 1(6): e190045.
    OpenUrl
  10. 10.↵
    Miller RJH, Shanbhag A, Killekar A, et al. AI-derived epicardial fat measurements improve cardiovascular risk prediction from myocardial perfusion imaging. NPJ Digit Med 2024; 7(1): 24.
  11. 11.↵
    Slomka PJ, Betancur J, Liang JX, et al. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol 2020; 27(3): 1010–21.
    OpenUrl
  12. 12.↵
    Slomka PJ, Nishina H, Berman DS, et al. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol 2005; 12(1): 66–77.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Otaki Y, Betancur J, Sharir T, et al. 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT. JACC Cardiovasc Imaging 2020; 13(3): 774–85.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107(23): 2900–7.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Wasserthal J, Breit HC, Meyer MT, et al. TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images. Radiol Artif Intell 2023; 5(5): e230024.
    OpenUrl
  16. 16.↵
    van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 2017; 77(21): e104–e7.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Miller RJH, Pieszko K, Shanbhag A, et al. Deep Learning Coronary Artery Calcium Scores from SPECT/CT Attenuation Maps Improve Prediction of Major Adverse Cardiac Events. J Nucl Med 2023; 64(4): 652–8.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Pieszko K, Shanbhag A, Killekar A, et al. Deep Learning of Coronary Calcium Scores From PET/CT Attenuation Maps Accurately Predicts Adverse Cardiovascular Events. JACC Cardiovasc Imaging 2023; 16(5): 675–87.
    OpenUrl
  19. 19.↵
    Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Jr., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15(4): 827–32.
    OpenUrlFREE Full Text
  20. 20.↵
    Motwani M, Dey D, Berman DS, et al. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J 2017; 38(7): 500–7.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Molinaro AM, Simon R, Pfeiffer RM. Prediction error estimation: a comparison of resampling methods. Bioinformatics 2005; 21(15): 3301–7.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. arXiv; 2017.
  23. 23.↵
    Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011; 32(8): 1012–24.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    Group ITR, Maron DJ, Hochman JS, et al. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J 2018; 201: 124–35.
    OpenUrlCrossRefPubMed
  25. 25.↵
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3): 837–45.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Pencina MJ, D’Agostino RB, Sr.., D’Agostino RB, Jr.., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27(2): 157–72; discussion 207-12.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Singh A, Miller RJH, Otaki Y, et al. Direct Risk Assessment From Myocardial Perfusion Imaging Using Explainable Deep Learning. JACC Cardiovasc Imaging 2023; 16(2): 209–20.
    OpenUrl
  28. 28.↵
    Hu LH, Miller RJH, Sharir T, et al. Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT. Eur Heart J Cardiovasc Imaging 2021; 22(6): 705–14.
    OpenUrl
  29. 29.↵
    Feher A, Pieszko K, Miller R, et al. Correction to: Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imaging. J Nucl Cardiol 2023; 30(2): 860–3.
    OpenUrl
  30. 30.↵
    Alahdab F, El Shawi R, Ahmed AI, Han Y, Al-Mallah M. Patient-level explainable machine learning to predict major adverse cardiovascular events from SPECT MPI and CCTA imaging. PLoS One 2023; 18(11): e0291451.
    OpenUrl
  31. 31.↵
    Miller RJH, Shanbhag A, Killekar A, et al. AI-Defined Cardiac Anatomy Improves Risk Stratification of Hybrid Perfusion Imaging. JACC Cardiovasc Imaging 2024.
  32. 32.↵
    Ashrafinia S, Dalaie P, Schindler TH, Pomper MG, Rahmim A. Standardized Radiomics Analysis of Clinical Myocardial Perfusion Stress SPECT Images to Identify Coronary Artery Calcification. Cureus 2023; 15(8): e43343.
    OpenUrl
  33. 33.↵
    Amini M, Pursamimi M, Hajianfar G, et al. Machine learning-based diagnosis and risk classification of coronary artery disease using myocardial perfusion imaging SPECT: A radiomics study. Sci Rep 2023; 13(1): 14920.
    OpenUrl
  34. 34.↵
    Flotats A, Knuuti J, Gutberlet M, et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging 2011; 38(1): 201–12.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Hicks R, Lau E, Binns D. Hybrid imaging is the future of molecular imaging. Biomed Imaging Interv J 2007; 3(3): e49.
    OpenUrlPubMed
  36. 36.↵
    Al-Mallah MH, Bateman TM, Branch KR, et al. 2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging. J Nucl Cardiol 2022; 29(6): 3491-535.
    OpenUrl
  37. 37.↵
    Gratz S, Kempke B, Kaiser W, Behr TM, Pfestroff A, Hoffken H. Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography. Nucl Med Commun 2008; 29(11): 963–9.
    OpenUrlCrossRefPubMed
  38. 38.↵
    Williams KA, Hill KA, Sheridan CM. Noncardiac findings on dual-isotope myocardial perfusion SPECT. J Nucl Cardiol 2003; 10(4): 395–402.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    Chamberlin JH, Smith C, Schoepf UJ, et al. A deep convolutional neural network ensemble for composite identification of pulmonary nodules and incidental findings on routine PET/CT. Clin Radiol 2023; 78(5): e368–e76.
    OpenUrl
  40. 40.↵
    Smith C, Nance S, Chamberlin JH, et al. Application of an artificial intelligence ensemble for detection of important secondary findings on lung ventilation and perfusion SPECT-CT. Clin Imaging 2023; 100: 24–9.
    OpenUrl
Back to top
PreviousNext
Posted April 24, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction
Anna M Michalowska, Wenhao Zhang, Aakash Shanbhag, Robert JH Miller, Mark Lemley, Giselle Ramirez, Mikolaj Buchwald, Aditya Killekar, Paul B Kavanagh, Attila Feher, Edward J Miller, Andrew J Einstein, Terrence D Ruddy, Joanna X Liang, Valerie Builoff, David Ouyang, Daniel S Berman, Damini Dey, Piotr J Slomka
medRxiv 2024.04.23.24305735; doi: https://doi.org/10.1101/2024.04.23.24305735
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction
Anna M Michalowska, Wenhao Zhang, Aakash Shanbhag, Robert JH Miller, Mark Lemley, Giselle Ramirez, Mikolaj Buchwald, Aditya Killekar, Paul B Kavanagh, Attila Feher, Edward J Miller, Andrew J Einstein, Terrence D Ruddy, Joanna X Liang, Valerie Builoff, David Ouyang, Daniel S Berman, Damini Dey, Piotr J Slomka
medRxiv 2024.04.23.24305735; doi: https://doi.org/10.1101/2024.04.23.24305735

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3284)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13346)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5138)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14617)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4909)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)